Status:
UNKNOWN
Neuroaxial Blokade and Blood Pressure
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Hypovolemia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The effect of individualized fluid optimization during neuroaxial blockade has not been evaluated. The investigators evaluated if if Stroke decrease 15 min after activation of neuroaxial blockade and ...
Detailed Description
The purpose of this study is to evaluate SV maximization with aid of the LiDCO system which is a minimal invasive technique only requiring a venous and arterial line. We thereby attempt to cover the s...
Eligibility Criteria
Inclusion
- Neuroaxial blockade (thoracic)
Exclusion
- Weight below 40 kg
- Lithium therapy
- Type I diabetes or type II requiring insulin
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00435422
Start Date
January 1 2010
End Date
May 1 2010
Last Update
March 25 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, 2100